Capability details
Corbus is committed to leveraging our expertise in immunology to develop innovative new medicines that improve the lives of people living with inflammatory, fibrotic, and metabolic diseases, and cancer. Corbus` current pipeline includes small molecules that activate or inhibit the endocannabinoid system. It specializes in inflammation, fibrosis, cystic fibrosis, orphan diseases, dermatomyositis, systemic sclerosis, scleroderma, lupus, systemic lupus erythematosus , rare diseases.